ThrombUS+ Project Overview - Horizon Europe Networking Event June 2024

The document summarizes updated guidelines from the World Society of Emergency Surgery (WSES) for the diagnosis and treatment of acute appendicitis. It provides background on acute appendicitis and discusses ongoing controversies in diagnosis and management. An updated consensus conference was held in 2019 to revise the original 2015 WSES Jerusalem guidelines. The updated 2020 guidelines aim to provide evidence-based statements and recommendations on topics including diagnosis, non-operative management, timing of surgery, surgical treatment, grading of appendicitis severity, and antibiotic therapy.

The document summarizes updated guidelines from the World Society of Emergency Surgery (WSES) on the diagnosis and treatment of acute appendicitis. It reviews the literature from April 2015 to June 2019 on key topics including diagnosis, non-operative management, timing of appendectomy, surgical treatment, grading of appendicitis severity, management of perforated appendicitis, and antibiotic use. 48 statements and 51 recommendations were developed based on 157 reviewed articles, following the GRADE methodology for evaluating evidence quality and strength of recommendations. The guidelines aim to provide evidence-based guidance on diagnosis and all aspects of acute appendicitis management.

The document provides an overview of eHealth and telemedicine in wound care. It defines key terms like eHealth, mHealth, telehealth, and telemedicine. The document also reviews literature on the use of eHealth in wound care and evaluates solutions based on the MAST framework. While evidence is still limited, studies show benefits like improved access to care and increased job satisfaction for clinicians. The document provides guidance for clinicians considering implementing eHealth applications and recommends evaluating outcomes to ensure efficient use.

This downloadable slideset summarizes optimal evidence-based antiretroviral therapy management strategies for a series of challenging clinical cases and is based on a satellite symposium presented at HIV Glasgow 2016. Format: Microsoft PowerPoint (.ppt) File size: 1.32 MB Date posted: 11/11/2016

This document provides guidance on estimating population doses from medical x-ray procedures in Europe. It discusses estimating the frequency of x-ray exams, assessing patient doses, and presenting results. The key purposes are to observe trends in collective dose over time, determine contributions by exam type, and allow international comparisons. Proper population dose estimates require accounting for the age and sex distributions of patients, as medical exposures are not uniform across populations. Regular assessments inform authorities on high exposure groups to focus radiation protection efforts.

This document summarizes a presentation given by Anastasia Pharris of the European Centre for Disease Prevention and Control on infections among people who inject drugs. It finds that over 30,000 new HIV diagnoses in Europe in 2016 were due to injecting drug use, with most cases concentrated in Eastern Europe. While harm reduction efforts have made progress in some countries, people who inject drugs still face high burdens of HIV, hepatitis C, and other infections. The presentation calls for improved testing, treatment, and prevention programs targeting this group.

Detailed presentation of the Cancer & the Kidney International Network. Partnership opportunities.

This document provides an updated 2020 Core Curriculum for Percutaneous Cardiovascular Interventions in Europe. It aims to define the level of experience and knowledge required of interventional cardiologists. The curriculum promotes standardized education and training programs across countries. It recommends at least two years of postgraduate training in addition to four years of cardiology training to achieve competence. The curriculum covers general training aspects and specific components in 54 chapters, defining objectives, required knowledge, skills, behaviors, and attitudes for each.

This document discusses bladder cancer in Europe. It notes that bladder cancer is the fifth most common cancer in Europe, yet it receives relatively little funding and resources compared to its disease burden. This lack of investment has resulted in few treatment options, delayed diagnosis, and low survival rates. Currently, up to half of all people diagnosed with bladder cancer in Europe will die within five years. The document identifies smoking and occupational exposure to carcinogenic chemicals as the main preventable risk factors for bladder cancer. It calls for more European action to reduce these risk factors and improve early diagnosis, treatment, and outcomes for bladder cancer patients.

How EU funds have benefited research into PCa and future plans for FP9 Jan-Willem Van de Loo, DG Research and Innovation (EC)

The document summarizes a pilot study conducted in the UK that tested a tele-cardiology service using wireless electrocardiogram (ECG) devices. The devices transmitted ECG readings from primary care clinics to a monitoring center where clinicians interpreted the results and provided advice. The pilot found the tele-cardiology service improved patient care by expediting diagnosis, eliminating some emergency visits, and increasing information quality for hospital visits. It also identified potential for huge cost savings compared to standard care.

Presentation from the 3rd Joint Meeting of the Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Networks, organised by the European Centre of Disease Prevention and Control - Stockholm, 11-13 February 2015

This document provides an overview of eHealth in the WHO European Region. It begins with an introduction that discusses universal health coverage and the European Health Information Initiative. It then covers several topics related to eHealth including electronic health records, telehealth, mHealth, eLearning in health, social media in health, health analytics and big data in health, and legal frameworks for eHealth. Each section provides data from the 2015 WHO global survey on eHealth in the European Region. The document concludes by recognizing the progress made by countries in adopting eHealth and highlighting emerging areas like big data and social media that hold potential to further improve health care and policy.

The document discusses EU initiatives on organ donation and transplantation, including a directive and action plan. The action plan aims to increase organ availability, make transplantation systems more efficient and accessible, and improve quality and safety. It outlines 10 priority actions to achieve these goals, such as promoting quality improvement programs in hospitals and developing common accreditation systems. The directive and action plan seek to establish common standards and policies across EU countries to strengthen cooperation on organ donation and transplantation.

This document provides clinical practice statements for the management of patients with venous leg ulcers. It aims to identify barriers and facilitators to implementing best practices based on guidelines. The document was created by an international expert working group to account for differences in healthcare systems worldwide and address gaps in current guidelines. Clinical practice statements cover the differential diagnosis and assessment of leg ulcers, treatment delivery including dressings and invasive options, referral structures, secondary prevention after healing, and outcome monitoring. The goal is to improve leg ulcer management and enhance the patient experience.

The document discusses the potential benefits of eHealth (ICT for health) in Europe. It notes that while the health sector employs over 9% of the EU workforce, ICT penetration in health is relatively low compared to other sectors. eHealth can improve efficiency and productivity, support chronic disease management and preventive care, and empower patients. The EU is a world leader in deploying ICT in primary care settings. Further development of eHealth requires addressing issues like interoperability, business models, and research into areas like personalized medicine.

The expert group meeting discussed hepatitis E virus (HEV) epidemiology, surveillance, and risks in the EU/EEA. HEV is an under-surveilled cause of hepatitis worldwide with different genotypes infecting people. While most EU cases were previously travel-related, HEV genotype 3 is now endemic in Europe with an animal reservoir. Surveillance varies between countries with no EU-wide system. The group aims to inventory HEV in Europe by surveying countries on surveillance methods and collecting case numbers to describe epidemiology and populations at risk. This will identify needs for EU guidance on diagnosis, risk assessment, and prevention strategies to respond to HEV health threats.

Lipids